| HGNC Family | G protein-coupled receptors |
| Name | tachykinin receptor 2 |
| Description | This gene belongs to a family of genes that function as receptors for tachykinins. Receptor affinities are specified by variations in the 5'-end of the sequence. The receptors belonging to this family are characterized by interactions with G proteins and 7 hydrophobic transmembrane regions. This gene encodes the receptor for the tachykinin neuropeptide substance K, also referred to as neurokinin A. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nInsulin receptor substrate‐2 (IRS2) is a central adaptor protein that transduces signals from the insulin and insulin‐like growth factor receptors to promote cell growth, survival, and metabolism. In the endocrine pancreas, IRS2 is indispensable for maintaining beta‐cell mass and function, as it mediates actions of incretin hormones and glucose to prevent apoptosis and stimulate proliferation. Its expression is tightly regulated by transcription factors and kinases—including CREB, CaMK4, and ATF3—to support compensatory beta‐cell expansion under insulin resistance, thus delaying diabetes onset."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the central nervous system, IRS2 plays a neuroprotective role and modulates energy homeostasis that influences both cognitive function and longevity. Reduced IRS2 signaling in the brain is linked to extended lifespan and enhanced metabolic parameters in animal models, whereas its dysregulation is associated with impaired neuronal proliferation, tau hyperphosphorylation, and accumulation of neurotoxic aggregates. These findings provide a molecular link between insulin resistance, neurodegenerative processes, and cognitive decline observed in conditions such as Alzheimer’s disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond the pancreas and brain, IRS2 serves as a critical regulator in peripheral tissues such as liver, muscle, kidney, and even the retina. In the liver, IRS2 helps coordinate the balance between gluconeogenesis and lipogenesis, with its zonal expression contributing to the phenomenon of selective insulin resistance observed in type 2 diabetes. In muscle and other insulin‐responsive tissues, IRS2 integrates complex signaling cascades—including Akt and MAPK pathways—thereby modulating glucose uptake, cellular growth and even impacting tumor progression. Structural studies have elucidated unique regions in IRS2 essential for its interaction with receptor kinases, and its phosphorylation by kinases such as JNK and GSK‐3 further fine‐tunes its signaling output."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ulupi S Jhala, Gianluca Canettieri, Robert A Screaton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.1097103"}], "href": "https://doi.org/10.1101/gad.1097103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12842910"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12842910"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Anita M Hennige, Deborah J Burks, Umut Ozcan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI18581"}], "href": "https://doi.org/10.1172/JCI18581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14617753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14617753"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xueying Lin, Akiko Taguchi, Sunmin Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI22217"}], "href": "https://doi.org/10.1172/JCI22217"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15467829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15467829"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Naoto Kubota, Yasuo Terauchi, Kazuyuki Tobe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI21484"}], "href": "https://doi.org/10.1172/JCI21484"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15467830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15467830"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xiaocheng Dong, Sunmin Park, Xueying Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI25735"}], "href": "https://doi.org/10.1172/JCI25735"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16374520"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16374520"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yasuo Terauchi, Iseki Takamoto, Naoto Kubota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI17645"}], "href": "https://doi.org/10.1172/JCI17645"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17200721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17200721"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "J Cantley, A I Choudhury, H Asare-Anane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-007-0637-9"}], "href": "https://doi.org/10.1007/s00125-007-0637-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17393136"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17393136"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Dan Li, Xin Yin, Erik J Zmuda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db07-0717"}], "href": "https://doi.org/10.2337/db07-0717"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18057093"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18057093"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Damien Demozay, Shin Tsunekawa, Isabelle Briaud, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db11-0341"}], "href": "https://doi.org/10.2337/db11-0341"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21940781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21940781"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Bo Liu, Helena Barbosa-Sampaio, Peter M Jones, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The CaMK4/CREB/IRS-2 cascade stimulates proliferation and inhibits apoptosis of β-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0045711"}], "href": "https://doi.org/10.1371/journal.pone.0045711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23049845"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23049845"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Markus Schubert, Derek P Brazil, Deborah J Burks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12904469"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12904469"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xianjin Yi, Markus Schubert, Neal S Peachey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3664-04.2005"}], "href": "https://doi.org/10.1523/JNEUROSCI.3664-04.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15689562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15689562"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Akiko Taguchi, Lynn M Wartschow, Morris F White "}, {"type": "b", "children": [{"type": "t", "text": "Brain IRS2 signaling coordinates life span and nutrient homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1142179"}], "href": "https://doi.org/10.1126/science.1142179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17641201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17641201"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Susanna Freude, Moritz M Hettich, Christina Schumann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.09-132043"}], "href": "https://doi.org/10.1096/fj.09-132043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19487308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19487308"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Eduardo D Martín, Ana Sánchez-Perez, José Luis Trejo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IRS-2 Deficiency impairs NMDA receptor-dependent long-term potentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cereb Cortex (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cercor/bhr216"}], "href": "https://doi.org/10.1093/cercor/bhr216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21955917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21955917"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Derek A Costello, Marc Claret, Hind Al-Qassab, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0031124"}], "href": "https://doi.org/10.1371/journal.pone.0031124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22383997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22383997"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "HongZhi Sun, Xiao Tu, Marco Prisco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2002-0276"}], "href": "https://doi.org/10.1210/me.2002-0276"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12554758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12554758"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Angela M Valverde, Deborah J Burks, Isabel Fabregat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/diabetes.52.9.2239"}], "href": "https://doi.org/10.2337/diabetes.52.9.2239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12941762"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12941762"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yanan Zheng, Hideomi Yamada, Ken Sakamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2005020193"}], "href": "https://doi.org/10.1681/ASN.2005020193"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15975995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15975995"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Sunmin Park, Xiaocheng Dong, Tracy L Fisher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M508307200"}], "href": "https://doi.org/10.1074/jbc.M508307200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16272563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16272563"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Yoshimi Nakagawa, Hitoshi Shimano, Tomohiro Yoshikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1334"}], "href": "https://doi.org/10.1038/nm1334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16327801"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16327801"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Hadar Sharfi, Hagit Eldar-Finkelman "}, {"type": "b", "children": [{"type": "t", "text": "Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00534.2007"}], "href": "https://doi.org/10.1152/ajpendo.00534.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18029441"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18029441"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jinhua Wu, Yolanda D Tseng, Chong-Feng Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.1388"}], "href": "https://doi.org/10.1038/nsmb.1388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18278056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18278056"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Rebecca A Haeusler, Domenico Accili "}, {"type": "b", "children": [{"type": "t", "text": "The double life of Irs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2008.06.010"}], "href": "https://doi.org/10.1016/j.cmet.2008.06.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18590687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18590687"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Naoto Kubota, Tetsuya Kubota, Shinsuke Itoh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2008.05.007"}], "href": "https://doi.org/10.1016/j.cmet.2008.05.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18590692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18590692"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Stefan Hanke, Matthias Mann "}, {"type": "b", "children": [{"type": "t", "text": "The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Proteomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/mcp.M800407-MCP200"}], "href": "https://doi.org/10.1074/mcp.M800407-MCP200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19001411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19001411"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Anke Assmann, Kohjiro Ueki, Jonathon N Winnay, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01489-08"}], "href": "https://doi.org/10.1128/MCB.01489-08"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19273608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19273608"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Kevin Wei, Stephanie M Piecewicz, Lisa M McGinnis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3295"}], "href": "https://doi.org/10.1038/nm.3295"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24037094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24037094"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Naoto Kubota, Tetsuya Kubota, Eiji Kajiwara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms12977"}], "href": "https://doi.org/10.1038/ncomms12977"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27708333"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27708333"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Sun-Hye Jeong, Han-Byul Kim, Min-Chul Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI95802"}], "href": "https://doi.org/10.1172/JCI95802"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29400692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29400692"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Tetsuya Kubota, Mariko Inoue, Naoto Kubota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-07358-9"}], "href": "https://doi.org/10.1038/s41467-018-07358-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30451856"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30451856"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Aurèle Besse-Patin, Stewart Jeromson, Philipa Levesque-Damphousse, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1815150116"}], "href": "https://doi.org/10.1073/pnas.1815150116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30770439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30770439"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "David L Morris, Kae Won Cho, Yingjiang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db08-1388"}], "href": "https://doi.org/10.2337/db08-1388"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19542202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19542202"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Francesca Buzzi, Linhua Xu, Richard A Zuellig, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00719-09"}], "href": "https://doi.org/10.1128/MCB.00719-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19933838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19933838"}]}]}]}
|
| Synonyms | NK2R, NKNAR, TAC2R, SKR |
| Proteins | NK2R_HUMAN |
| NCBI Gene ID | 6865 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TACR2 has 5,165 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 109 datasets.
Click the + buttons to view associations for TACR2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TACR2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TACR2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TACR2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TACR2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TACR2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TACR2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TACR2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TACR2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TACR2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TACR2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TACR2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TACR2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TACR2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TACR2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TACR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TACR2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TACR2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TACR2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TACR2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TACR2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TACR2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for TACR2 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with TACR2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TACR2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TACR2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TACR2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TACR2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TACR2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TACR2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TACR2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TACR2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TACR2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TACR2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TACR2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TACR2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TACR2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TACR2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TACR2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TACR2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TACR2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TACR2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing TACR2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TACR2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TACR2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TACR2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TACR2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TACR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TACR2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding TACR2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| Guide to Pharmacology Protein Ligands of Receptors | ligands (protein) binding TACR2 receptor from the curated Guide to Pharmacology Protein Ligands of Receptors dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for TACR2 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TACR2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TACR2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TACR2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TACR2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TACR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TACR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TACR2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TACR2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving TACR2 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TACR2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TACR2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TACR2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TACR2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TACR2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TACR2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TACR2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TACR2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TACR2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TACR2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TACR2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TACR2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TACR2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TACR2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TACR2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TACR2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving TACR2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving TACR2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TACR2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TACR2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TACR2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TACR2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TACR2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TACR2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TACR2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TACR2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TACR2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TACR2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TACR2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TACR2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TACR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TACR2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TACR2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TACR2 protein from the WikiPathways Pathways 2024 dataset. | |